NATHANIELSZ JAMES ANDREW (CEO, Acting CFO, Chairman) received a stock award from PROPANC BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 8/20/2021ACC: 0001493152-21-020758
DirectorOfficer· CEO, Acting CFO, Chairman
Since May 2019
+8.73M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
8.73M acquired
Non-Derivative Transactions2
Common stock, par value $0.001
Indirect
Shares
+5.93M
Price / share
—
Trade value
—
% of position
148200000.0%
8/17/2021
4.00→5.93M
Common stock, par value $0.001
Indirect
Shares
+2.80M
Price / share
—
Trade value
—
% of position
New position
8/17/2021
0.00→2.80M
Total
Net shares
+8.73M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 Indirect | 8/17/2021 | A · Award | +5.93M | — | — | 148200000.0% | 4.00 | 5.93M |
| Common stock, par value $0.001 Indirect | 8/17/2021 | A · Award | +2.80M | — | — | New position | 0.00 | 2.80M |
| Total | +8.73M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported